Parallax Volatility Advisers
APTO

Parallax Volatility Advisers’s Aptose Biosciences, Inc. APTO Stock Holding History

Parallax Volatility Advisers’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$5K – 3826
2018
Q2 		$5K Hold
3
– – ﹤0.01% 1832
2018
Q1 		$4K Hold
3
– – ﹤0.01% 1969
2017
Q4 		$3K Hold
3
– – ﹤0.01% 3856
2017
Q3 		$2K Sell
3
-4
-57% -$2.69K ﹤0.01% 1964
2017
Q2 		$4K Sell
7
-7
-50% -$3.37K ﹤0.01% 2034
2017
Q1 		$6K Buy
+14
New +$7.17K ﹤0.01% 3282

Other funds holding APTO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Parallax Volatility Advisers's APTO Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Aptose Biosciences, Inc. (APTO) in Q3 2018, closing a stake of 3 shares — an estimated $5K sold.

Parallax Volatility Advisers first reported a position in APTO in Q1 2017 and held it in 6 quarters. The position peaked at $6K in Q1 2017. 17 funds tracked by Wall St. Rank hold APTO as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining Aptose Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3 Aptose Biosciences, Inc. shares in Q3 2018, an estimated $5K.
  • Parallax Volatility Advisers first reported a position in Aptose Biosciences, Inc. in Q1 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Aptose Biosciences, Inc. position peaked at $6K in Q1 2017.
  • 17 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.